To
Dear Members,
Your Directors are pleasure to present the Fifth Annual Report on the business and operations of the Company along with audited financials for the period ended 31stMarch, 2025.
1.FINANCIAL HIGHLIGHTS:
The financial results for the year ended 31st March 2025 are furnished below.
| Particulars | 2024-2025 (Rs. In Lakhs) | 2023-2024 (Rs. In Lakhs) |
| Revenue from Operations | 4785.33 | 4303.74 |
| Other Income | 23.35 | 35.04 |
| Total Income | 4808.67 | 4338.78 |
| Less: Cost of Consumption | 1772.74 | 1696.39 |
| Less: Employee Benefit Expenses | 559.25 | 323.64 |
| Less: Finance Costs | 62.27 | 60.81 |
| Less: Other Expenses | 1629.48 | 1424.06 |
| Profit Before Exceptional and Extraordinary Items and Tax | 568.74 | 703.49 |
| Less: Exceptional Items | - | - |
| Less: Prior Period Item | - | ss |
| Less: Depreciation | 215.8 | 130.39 |
| Less: Tax Expenses | 133.84 | |
| (i). Current Tax | 165.31 | |
| (ii). Deferred Tax | 13.77 0.46 | (12.4) |
| (iii). Tax Adjustment for earlier years | ||
| Profit After Tax | 420.67 | 524.84 |
2. COMPANY STATE OF AFFAIRS
During the financial year 2024-25, the Total Operating Income of the Company increased to Rs. 4,785.33 lakhs as compared to Rs. 4,303.74 lakhs in the previous year.
The Profit After Tax (PAT) for the year under review was Rs. 420.67 lakhs, as against Rs. 524.84 lakhs in the previous year. The reduction in profitability is primarily attributable to higher depreciation charges.
Depreciation for the year stood at Rs. 215.80 lakhs, as against Rs. 130.39 lakhs in the previous year, consequent to additions to fixed assets and capital expenditure undertaken by the Company.
3. DIVIDEND
Board has not recommended dividend for the financial year 2024-25 keeping in view the longterm objectives of the Company.
4. CHANGE IN STATUS OF THE COMPANY
During the year, your company converted itself into a Public Limited Company with effect from 6th June 2024. Also, your company is listed with BSE SME platform with effect from 21st February 2025.
5. RESERVES
The Company has not transferred any amount to General reserve during the year.
6. CHANGE IN NATURE OF BUSINESS
There is no change in the nature of business of your Company
7. SHARE CAPITAL
• During the year the Authorised Share Capital of the Company is Rs.14,00,00,000/- (Rupees Fourteen Crores only) divided into 1,40,00,000 (One Crore Forty Lakh shares) Equity Shares of face value Rs. 10/- (Rs. Ten).
• Pursuant to the Initial Public Offer of Equity Shares by the Company, the Board of Directors, in their meeting held on February 18, 2025, has allotted total 38,18,000 (Thirty-Eight Lakh Eighteen Thousand) Equity Shares Rs. 10/- (Rupees Ten Only) each at price of Rs. 54/- (Rupees Fifty-Four Only) per Equity Share [Including a share premium of Rs. 44/- (Rupees Forty-Four Only) Per Equity Share to the successful allottees, whose list have been finalized by the Company, the Registrar to the issue and merchant banker in consultation with Bombay Stock Exchange (BSE).
• The Paid-up share capital of the company as on 31st March, 2025 is Rs. 13,61,30,000/- (Rupees Thirteen Crores Sixty-One Lakhs and Thirty Thousand Only) divided into 1,36,13,000 Equity Shares of Rs. 10/- each.
a. BUY BACK OF SECURITIES:
The Company has not bought back any of its securities during the year under review.
b. SWEAT EQUITY:
The Company has not issued any Sweat Equity Shares during the year under review.
c. BONUS SHARES:
The Company has not issued any Bonus Shares during the year under review.
d. RIGHTS ISSUE
The Company has not issued any Rights Issue during the year under review.
e. EMPLOYEES STOCK OPTION PLAN:
The Company has not provided any Stock Option Scheme to the employees.
9. CREDIT RATING
As your company has not availed any credit facility requiring credit rating. Hence, the company did not obtain credit rating.
10. TRANSFER OF SHARES / AMOUNT TO IEPF
During the year under review, the Company had not transferred any amount or Shares to the Investor Education and Protection Fund.
11. DETAILS OF SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR TRIBUNALS IMPACTING THE GOING CONCERN STATUS AND COMPANYS OPERATIONS IN FUTURE
There are no significant and material orders passed by the Regulators / Courts or tribunals that would impact the going concern status of the Company and its future operations.
12. MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY WHICH HAVE OCCURRED BETWEEN THE END OF THE FINANCIAL YEAR OF THE COMPANY TO WHICH THE FINANCIAL STATEMENTS RELATE AND THE DATE OF THE REPORT
Nil
13. INTERNAL FINANCIAL CONTROL AND RISK MANAGEMENT
The company has an established Internal Financial Control framework including internal controls over financial reporting, operating controls and anti-fraud framework. The frame work is reviewed regularly by the Management and tested by internal audit team and presented to the Audit Committee. Based on periodical testing, the framework is strengthened from time to time, to ensure adequacy and effectiveness of Internal Financial Control. The established controls are constantly assessed and strengthened with new / revised standard operating procedures. The Company has adopted policies and procedures for ensuring adherence to the Companys policies, safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and reliability of accounting records and timely preparation of reliable financial disclosures.
14. PENALTIES / PUNISHMENT/ COMPOUNDING OF OFFENCES
During the financial year 2024-25, no penalties have been imposed on the company by any regulatory authorities.
15. PUBLIC DEPOSITS
The Company has not accepted any deposit from the public within the meaning of Chapter V of the Companies Act 2013 during the year ended 31stMarch 2025.
16. INTERNAL AUDITORS
Section 138 of the Companies Act, 2013 read with Rule 13 of the Companies (Accounts) Rules, 2014 and based on the recommendations made by the Audit Committee M/s. JV & Co, Chartered Accountants, Salem has been appointed as the Internal Auditors for carrying out the Internal Audit of the company for the FY 2024-25.
17. STATUTORY AUDITORS
Section 139 of the Companies Act, 2013 provided for the appointment of Statutory Auditors for a period of five years and hence M/s P P N AND COMPANY, Chartered Accountant (Firm Registration No. 013623s), Chennai were appointed as the Statutory Auditors of the Company in the Annual General Meeting of the Company held on 30th September 2023 for a period till the conclusion of the Eighth Annual General Meeting.
18. SECRETARIAL AUDITORS
Pursuant to Section 204 of the Companies Act, 2013 and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company has appointed M/s. Suryah & Dinesh Associates LLP, Practicing Company Secretaries, as the Secretarial Auditors of the Company in the Board Meeting held on 31st March 2025, for the FY 2025-26. The Secretarial Audit Report issued by the Companys Secretarial Auditor M/s. Suryah & Dinesh Associates LLP is annexed and forms part of this Report in "Annexure-IN". The report does not contain any qualification.
19. COST AUDITORS
The Company is required to maintain cost records as specified under Section 148(1) of the Companies Act, 2013. However, the provisions relating to cost audit are not applicable to the Company and accordingly, no cost auditor has been appointed
20. STATUTORY AUDITORS REPORT
The Statutory Auditors Report for the Financial Year 2024-25 does not contain any qualification, reservation or adverse remarks and the same is enclosed with the audited financial statements in this Annual Report.
21. ANNUAL RETURN
The Draft Annual Return of the Company is available on the companys website: https://shanmugahospital.com/annual-return/
22. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO
Particulars in respect of conservation of energy, technology absorption and foreign exchange earnings and outgo, pursuant to the provisions of Section 134 (3) (m) of the Companies Act, 2013, are given in "ANNEXURE - I" to this report.
23. BOARD OF DIRECTORS
Pursuant to the provisions of Section 203 of the Companies Act, 2013, the Board of Directors is duly constituted.
| Sr. No |
din/pan | Name | Designation |
| 1 | 8772887 | Dr. PALANIAPPAN SHANMUGAM PANNEERSELVAM | Managing Director |
| 2 | 8772888 | Dr. PANNEERSELVAM PRABU SANKAR | Executive Director & CEO |
| 3 | 10692764 | Mrs. PANNEERSELVAM JAYALAKSHMI | Executive Director |
| 4 | 10469316 | Dr. DHANDAPANI PRIYADHARSHNI | Non-Executive Director |
| 5 | 10692765 | Mr. KARUPPIAH SARAVANAN | Non-Executive Director |
| 6 | 10670386 | CS BHOOPATHY AKILAN# | Independent Director |
| 7 | 7830578 | CS GOWRI% | Independent Director |
| 8 | 9217524 | Mr. RAJKUMAR ASHWIN% | Independent Director |
% CA Gowri & Mr. Rajkumar Ashwin - Appointed as Independent Director at the EGM on
10.05.2024. # CS Bhoopathy Akilan - Appointed as Independent Director at the EGM on
21.06.2024.
DIRECTORS RETIRING BY ROTATION:
Dr. Panneerselvam Prabu Sankar, Executive Director & Chief Executive Officer and Dr. Dhandapani Priyadharshni, Non-Executive and Non-Independent Directors of the Company are liable to retire by rotation at the ensuing Annual General Meeting and being eligible offers themselves for re-appointment.
The profile of Dr. Panneerselvam Prabu Sankar & Dr. Dhandapani Priyadharshni is given in the Annexure to the Notice of the Annual General Meeting.
KEY MANAGERIAL PERSONNELS:
| Sl. No Name of the Key Managerial Personnels | Designation |
| 1 Dr. Panneerselvam Prabu Sankar | Chief Executive Officer |
| 2 Mr. Karthick | Chief Financial Officer |
| 3 CS Kannan Anjana Maragatham | Company Secretary & Compliance Officer |
During the year under review, following changes occurred in the composition of the Board of Directors and KMP:
| Sl. No. Name of the Director/KMP | Designation | Effective Date | Nature of Change |
| 1 Veera Pratap Reddy Gandluru | Company Secretary | 30.04.2024 | Resignation |
| 2 Dr. Rahul Mukherjee | Independent Director | 10.05.2024 | Appointment |
| 3 Anjana Maragatham | Company Secretary | 02.05.2024 | Appointment |
| 4 Dr. Rahul Mukherjee | Independent Director | 01.06.2024 | Resignation |
| 5 Anjana Maragatham | Company Secretary | 28.06.2024 | Resignation |
| 6 Veera Pratap Reddy Gandluru | Company Secretary | 28.06.2024 | Appointment |
| 7 Panneerselvam Jayalakshmi | Executive Director | 30.09.2024 | Change in Designation |
| 8 Karuppiah Saravanan | Non- Executive Director | 30.09.2024 | Change in Designation |
| 9 Veera Pratap Reddy Gandluru | Company Secretary | 24.03.2025 | Resignation |
| 10 Kannan Anjana Maragatham | Company Secretary | 31.03.2025 | Appointment |
| 11 Gowri | Independent Director | 10.05.2025 | Appointment |
| 12 Rajkumar AShwin | Independent Director | 10.05.2025 | Appointment |
| 13 B Akilan | Independent Director | 21.06.2024 | Appointment |
24. BOARD MEETING
During the year board has met 18 times the details as follows:
25. BOARD COMMITTEE
The company constituted three committees as per the Companies Act, 2013 read with SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, in order to fulfil the conditions specified for listing its shares with the Stock Exchange. The committees constituted by the Board are:
a) . Audit Committee
b) . Nomination Remuneration Committee
c) . Stakeholders Relationship Committee
The Composition and meeting held during the year are annexed as Annexure II.
GENERAL MEETING
During the year under review, the following General Meetings were held, the details of which are given as under:
| S.No Type of General Meeting | Date of General Meeting |
| 1 Extra Ordinary General Meeting | 10.05.2024 |
| 2 Extra Ordinary General Meeting | 21.06.2024 |
| 3 Annual General Meeting | 30.09.2024 |
26. CORPORATE SOCIAL RESPONSIBILITY
Corporate Social Responsibility (CSR) is an initiative brought in by the Ministry of Corporate Affairs whereby every company having net worth of rupees 500 Crores or more, or turnover of rupees 1000 Crores or more or a net profit of rupees 5 Crores or more during the immediately preceeding financial year is mandated to serve the society by contributing at least 2% of the average net profits of the Company made during the three immediately preceeding financial years in various CSR activities as defined in Schedule VII of the Companies Act, 2013.
The Company has duly constituted a Corporate Social Responsibility Committee as required under Section 135 (1) of the Companies Act, 2013 appended as Annexure and the relevant rules made thereunder and the Board has approved a policy on Corporate Social Responsibility which is available in the website of the Company. The Annual Report on your Companys CSR activities is appended as "Annexure-V" to the Boards Report.
27. COMPANIES WHICH HAVE BECOME OR CEASED TO BE THE SUBSIDIARIES / JOINT VENTURES / ASSOCIATE COMPANIES DURING THE YEAR
NIL
28. ANNUAL PERFORMANCE EVALUATION
In line with the criteria evolved by the Nomination and Remuneration Committee, the performance of the Board, Managing Director, other Directors, Committees, Key Managerial Personnel and Senior Executives have been evaluated considering various evaluation aspects.
29. DISCLOSURE OF ACCOUNTING TREATMENT
The Company has followed the Accounting Standards specified under the Companies (Accounts) Rules, 2014 (as amended) to the extent applicable, in the preparation of the financial statements.
30. POLICY ON VIGIL MECHANISM
Pursuant to the provisions of Section 177(9) of the Companies Act, 2013 read with Rule 7 of the Companies (Meetings of its Board and its Powers) Rules, 2014 the Company has an established Policy on Vigil Mechanism for Directors / Employees and other stakeholders of the Company to report concerns about unethical behaviors, actual or suspected fraud, or violation of the Companys Code of conduct or ethics policy. The policy also provides a direct access to the Chairman of the Audit Committee to make protective disclosures to the management about the grievances or violation of the Companys code of conduct. The policy www.shanmugahospital.com
31. POLICIES
The Board of Directors of the Company have from time to time framed and approved various Policies in pursuance of the Companies Act, 2013 and the Listing Agreement/ SEBI (LODR) Regulations, 2015. These Policies and Codes are reviewed by the Board and are updated, if required. The following policies have been framed and are published in the Companys website
1. Code for Independent Directors.
2. Code of Conduct for Board Members and Senior Management.
3. Policy for determination of Materiality of Events.
4. Policy for Preservation of Documents.
5. Policy on Sexual Harassment of Women at Workplace.
6. Related Party Transaction Policy.
7. UPSI Policy.
8. Vigil Mechanism / Whistle Blower Policy.
9. Terms and Conditions of Appointment of Independent Directors.
10. Nomination and Remuneration Policy.
11. Criteria for making payments to Non-Executive Directors.
12. Policy on Archival of Documents.
32. DISCLOSURES UNDER SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION & REDRESSAL) ACT, 2013:
The Company has in place a Policy on prevention of Sexual Harassment, in accordance with the requirements of the Sexual Harassment of Women at workplace (Prevention, Prohibition and Redressal) Act, 2013. All employees are covered under this policy. The Company has complied with the provisions relating to the constitution of Internal Complaints Committee under the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (POSH).
The company had not received any Complaints under Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 during the financial year 2024-2025.
| No. of complaints of sexual harassment received in the | No. of complaints disposed off during the year | No. of cases pending for more than ninety days |
| 0 | 0 | 0 |
33. PREVENTION OF INSIDER TRADING
The Company has adopted a code for prevention of insider trading with a view to regulate trading and securities by the Directors and designated employees of the Company. The code requires preclearance for dealing in the Companys securities and prohibits the purchase or sale of Companys Securities while in possession of unpublished price sensitive information and during the period when the trading window is closed. The company maintains a structured digital database called "PIT Archive" software wherein the details of all the designated persons are being captured in compliance with Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
34. DISCLOSURE OF PARTICULARS OF LOANS/ADVANCES/lNVESTMENTS OUTSTANDING DURING THE FINANCIAL YEAR
The Company has not given any loans and advances to any other body corporate and associates as specified under Section 186 of the Companies Act, 2013 during the financial year 2024-25.
The details of the investments made by the Company and guarantees provided by the Company are given in the notes to the financial statements.
35. PARTICULARS OF CONTRACTS OR ARRANGEMENTS WITH RELATED PARTIES
During the financial year 2024-25 the contracts and arrangements entered by the Company with related parties were on an "arms length" basis and in the ordinary course of business. There are no materially significant related party transactions made by the Company with Promoters, Directors, Key Managerial Personnel or other designated persons, which may have a potential conflict with the interests of the Company at large. The policy on dealing with Related Party Transactions as approved by the Board is uploaded on the Companys website.
The details of contracts or arrangements with related parties entered during the year are given in a separate report as "Annexure-IV".
36. REPORT ON CORPORATE GOVERNANCE, DECLARATION BY CEO AND COMPLIANCE CERTIFICATE ON CORPORATE GOVERNANCE EITHER FROM A PRACTICING CHARTERED ACCOUNTANT OR PRACTICING COMPANY SECRETARY
Your company is listed with BSE Small and Medium Enterprise Platform and is exempted from the disclosures specified in Para C, D and E of Schedule V of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015. Hence the above disclosures are not applicable to your Company.
37. DECLARATION OF COMPLIANCE WITH CODE OF CONDUCT UNDER SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015
All the Directors and Senior Management personnel of the Company have affirmed compliance with the Code of Conduct, as applicable to them, for the financial year ended 31st March, 2025.
38. MANAGEMENT DISCUSSION AND ANALYSIS REPORT
Management Discussion and Analysis for the year, as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, is presented in a separate section forming part of the Annual Report as "ANNEXURE - VI"
39. PARTICULARS OF EMPLOYEES
The ratio of the remuneration of each director to the median of employees remuneration as per Section 197(12) of the Companies Act, 2013, read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 is annexed to this Report as "Annexure-VII".
40. DIRECTORS RESPONSIBILITY STATEMENT AS REQUIRED UNDER SECTION 134 (5) OF THE COMPANIES ACT, 2013
IN TERMS OF PROVISIONS OF SECTION 134(5) OF THE COMPANIES ACT, 2013, YOUR DIRECTORS CONFIRM THAT:
(i) In the preparation of the annual accounts, the applicable accounting standards had been followed along with a proper explanation relating to material departures.
(ii) The directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the profit of the company for that period.
(iii) The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities.
(iv) The directors had prepared the annual accounts on a going concern basis.
(v) The directors, had laid down internal financial controls and such internal financial controls are adequate and were operating effectively.
(vi) The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.
41 DETAILS IN RESPECT OF FRAUDS REPORTED BY AUDITORS UNDER SUB-SECTION (12) OF SECTION 143 OTHER THAN THOSE WHICH ARE REPORTABLE TO THE CENTRAL GOVERNMENT
The Statutory Auditors have stated that, no fraud by the Company or no material fraud on the Company by its officers and employees had been noticed or reported during the year.
42 DECLARATIONS GIVEN BY INDEPENDENT DIRECTORS
All the Independent Directors of the Company have given their declaration under Section 149 (7) of the Companies Act, 2013, confirming that they are in compliance with the criteria as laid down in the said Section for being an Independent Director of the Company. Further, there has been no change in the circumstances which may affect their status as Independent Director during the year.
The Statement of Declaration of Independence from Independent Directors that they meet the criteria of independence as provided in sub-section (6) of Section 149 of the Companies Act, 2013 and the relevant rules and Regulation 16(1)(b) of SEBI Listing Regulations has been obtained from the Independent Directors and the Board has taken on record the same. All the Independent Directors have registered with the databank of Independent Directors developed by the Indian Institute of Corporate Affairs in accordance with the provisions of Section 150 of the Act, 2013 and obtained Independent Director registration certificate. Further the Independent Directors have also declared that in the event of expiry of their registration with the Data bank, they shall take the necessary steps to renew their registration in accordance with the applicable provisions of the Companies Act 2013 read with rules made thereunder.
43. THE DETAILS OF APLICATION MADE OR ANY PROCEEDINGS PENDING UNDER THE INSOLVENCY AND BANKRUPTCY CODE, 2016 (31 OF 2016) DURING THE YEAR
Your Company confirms that no application against the Company has been filed or is pending under the Insolvency and Bankruptcy Code 2016 during the year under review. Your Company further confirms there are no past applications or proceedings under the Code.
44. SECRETARIAL STANDARDS
The Company has complied with all applicable Secretarial Standards in pursuant to the directions of Ministry of Corporate Affairs, issued by the Institute of Company Secretaries of India during the year.
45. DISCLOSURES WITH RESPECT TO DEMAT SUSPENSE ACCOUNT / UNCLAIMED SUSPENSE ACCOUNT AS PER PARA F OF SCHEDULE V OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.
| Particulars | Remarks |
| Aggregate number of shareholders and the outstanding shares in the suspense account lying at the beginning of the year | NIL |
| Number of shareholders who approached listed entity for transfer of shares from suspense account during the year | |
| Number of shareholders to whom shares were transferred from suspense account during the year | |
| Aggregate number of shareholders and the outstanding shares in the suspense account lying at the end of the year | |
| The voting rights on these shares shall remain frozen till the rightful owner of such shares claims the shares |
46. DETAILS OF DIFFERENCE BETWEEN AMOUNT OF THE VALUATION DONE AT THE TIME OF ONE TIME SETTLEMENT AND THE VALUATION DONE WHILE TAKING LOAN FROM THE BANKS OR FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF
NIl
47. INTELLECTUAL PROPERTY OF COMPANY
We are proud to report that our company successfully applied for and received approval for two trademarks from the Office of the Controller General of Patents, Designs and Trade Marks. These registered trademarks mark a significant milestone in protecting our brand identity and reinforcing our commitment to innovation and quality. Securing these rights ensures legal protection and strengthens our market presence. It also reflects our strategic focus on building long-term value through intellectual property. The trademarks will play a vital role in distinguishing our products and services in a competitive landscape. We remain committed to safeguarding our brand and expanding our IP portfolio in the years ahead.
48. BSE CORPORATE COMPLIANCE & LISTING CENTRE (THE LISTING CENTRE)
BSEs Listing Centre is a web-based application designed for corporate. All periodical compliance filings like shareholding pattern, financial results, reconciliation of Share capital audit, among others are also filed electronically on the Listing Centre.
49. SEBI COMPLAINTS REDRESS SYSTEM (SCORES)
Investors complaints are processed in a centralized web-based complaints redress system. The salient features of this system are: Centralized database of all complaints, online upload of Action Taken Reports (ATRs) by concerned companies and online viewing by investors of actions taken on the complaint and its current status. The Company regularly redresses the complaints if any, on SCORES within stipulated time.
50. DESIGNATED EXCLUSIVE EMAIL-ID
The Company has designated the email-id: secretarial@shanmugahospital.com exclusively for investor servicing.
51. LISTING FEES:
The Company confirms that it has paid the Annual Listing Fees for the year 2025-26 to BSE Limited, Stock Exchange where the companys shares are listed.
52. ACKNOWLEDGEMENTS AND APPRECIATION
The Board of Directors of the Company wishes to place on record their deep sense of gratitude to all the Shareholders of the Company for their consistent support and continued faith reposed in the Company. The Board also expresses its deep sense of appreciation to the various Central and State Government Departments, Bankers, Organizations and Agencies, external Professionals associated with the Company for their help and co-operation extended by them and last but not the least, to Employees at all levels for their hard work and commitment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.